ebulus we aimed to prepare a topical formulation from methanolic extract of this herb, to investigate its effects on uremic pruritus.
Materials and methods
S. ebulus fruits were collected from Sari suburb, Iran in September 2015. The samples were confirmed by Plant systematic specialist and have been deposited in herbarium (Qaemshahr branch, Islamic Azad University, Qaemshahr, Iran). Fruits were dried at room temperature and away from sunlight. 500 grams of powdered sample was fractionated by successive solvent extraction at room temperature by percolation with hexane (2.4 L × 3) then ethyl acetate (2.4 L × 3) and finally methanol (2.4 L × 3). Toxicity in ethyl acetate fraction and safety in methanol fraction have been improved (15) . The resulting methanol extract was the concentrated over a rotary vacuum evaporator (30-35 °C) until a solid extract sample was obtained. The resulting crude extracts were freeze-dried.
Determination of total phenolic compounds and flavonoid contents
Total phenolic compound contents were determined by the Folin-Ciocalteau method. The extract sample (0.5 mL) was mixed with 2.5 mL of 0.2 N Folin-Ciocalteau reagent for 5 min and 2.0 mL of 75 g/L sodium carbonate was then added. The absorbance of reaction was measured at 760 nm after 2 h of incubation at room temperature. Results were expressed as gallic acid equivalents. Total flavonoids were estimated using our recently publish papers (16) . In other words, 0.5 mL solution of extract in methanol were mixed with 1.5 mL of methanol, 0.1 mL of 10% aluminum chloride, 0.1 mL of 1 M potassium acetate, and 2.8 mL of distilled water and left incubated at room temperature for 30 minutes. The absorbance of the reaction mixture was measured at 415. Total flavonoid contents were calculated as quercetin from a calibration curve.
Preparation of the formulations
The extract was dissolved in solvent system containing tween 80, preserved water (methyl paraben 0.18% and propyl paraben 0.02%) and ethanol. Several concentrations of HPMC (2-6%) and carbopol (0.3-1%) were used as gelling agent. The polymer was dispersed in this solution for overnight. The system was homogenized and neutralized by triethanolamine in formulations containing carbopol as gelling agent. The formulations were kept in 4 ºC, 25 ºC and 40 ºC for physical stability evaluation (viscosity, syneresis, swelling, color change) during 2 weeks (17). The selected formulation for clinical trial was controlled microbiologically based on USP 30 (United States Pharmacopoeia 30) (18) .
Clinical assessments
The study was a randomized, single blind, placebocontrolled clinical trial and approved by the Research Ethics Committee of the council of Mazandaran University of Medical Sciences (IRCT 2016102810203NF). Seventy eight patients with uremic pruritus after giving written informed consent divided into two group randomly case group and control group. Patients were included if they had endstage renal disease, were on hemodialysis for at least 3 months, 18 years old or older, experience at least 3 episodes of itching in last 2 weeks, xerosis without edema, despite medication intake in the last month of treatment, no evidence of improvement was observed. Patients with systemic disease such as cholestatic liver disease, hepatitis B and C, HIV, thyroid disorder, patients with skin disorder such as eczema and atopic dermatitis, lactating and pregnant women, patients with allergy to Sambucus ebulus gel, patients who received cholestyramine and UVB therapy, patients with psychotic illness or other communications problems were excluded from the study (5) . The following demographic, clinical and laboratory characteristics including age, gender, duration of dialysis, duration of itching, other systemic disease (Etiology of ESRD), Medications including, oral antihistamines and local steroids, and values of the most recent laboratory studies (haemoglobin, calcium, phosphorus, parathyroid hormone (PTH), pre and postdialysis creatinine, pre and post-dialys is blood urea nitrogen, albumin, liver enzymes, adequacy of dialysis expressed as K t /V, uric acid, fasting blood sugar) were recorded. Case group"s patients used S. ebulus gel and control group"s patients used placebo gel twice a day for 8 weeks. Each person received cetrizin 10mg/day. At the first visit, 4 th week,8 th week, the pruritus severity was determined using a scale ranging from 1 to 48 where 48 was the most severe itch imaginable ( At each visit drug sides effect including edema, erythema, burning, itching and pigmentation (hyperpigmentation and hypopigmentation) were investigated.
Statistical analysis
Quantitative data between two groups were compared by T-student test and qualitative data was compared by Chi-square and Fisher's exact test. In all cases, p < 0.05 was taken as statistically significant.
Results

Baseline characteristics
The extract was standardized by its total phenol and flavonoids contents as the main therapeutical compounds in this plant. The total phenolic content was 190.37 mg gallic acid equivalent/g of extract by reference to standard curve (Abs. = 0.0054Conc. + 0.062, r 2 = 0.999).The total flavonoid content was 24.6 mg quercetin equivalent/g of extract, by reference to standard curve (Abs. = 0.0063Conc. -0.0075, r 2 = 0.999).
A total of 78 patients were recruited in the present study by a single investigator, 61 participants completed this study 17 patients were excluded from the efficacy analyses. Two patients suffered from allergic reactions one in control group and one in case group and 13 patients (7 persons in case group and 6 persons in control group) discontinued treatment due to personal reasons, one patient in each group discontinued study because of death. All of the 61 subjects (31 patients in case group and 30 patients in control group) completed 8 weeks treatment (Fig. 1) .
The basic demographic, clinical and laboratory Data characteristics of the participants are summarized in (Table 2 ) Patients in control group were older than case group, and had higher duration of hemodialysis, duration of itching, FBS, ALT, AST, ALP, albumin, post-dialysis creatinine, K t /V, PTH than patients in case group but there were no significant differences among these factors between patients in two groups. Case group had significant higher level of phosphorus, hemoglobin and pre-dialys is BUN compared with control group.
Efficacy
At baseline, no significant difference was observed between groups in mean pruritus severity scores (P =0.2630). This similarity was observed between groups in the number of patients (%) with xerosis in the pruritus area (P = 0.5077) and number of patients (%) who making themselves bleed from scratching (P = 0.443) too.
Pruritus severity
At baseline (Fig. 2) , the mean scores of pruritus severity in two groups were 20.53 ± 9.08 and 23.44 ± 10.36, respectively. Patients in both groups experienced significant decrease in pruritus severity scores in comparison with baseline at 4 th week 10.07 ± 6.78 (P ˂ 0.0001) and 9.74 ± 9.749 (P ˂ 0.0001) and at 8 th week
7.43 ± 7.75 (P ˂ 0.0001), 7.04 ± 9.81 (P ˂ 0.0001).
There was no significant difference in mean of pruritus severity between two groups at 4 th and 8 th week (P = 0.8831 and P = 0.8656 respectively). 
Xerosis in pruritus area
At baseline (Fig. 3 ) the number of patients (%) suffered from xerosis in case and control groups were 77.41% and 86.66% respectively (P= 0.5077). There was no significant reduction of xerosis in two groups (P = 0.9189, P = 0.9022 respectively) during treatment.
Bleeding from scratching
Numbers of patients who making themselves bleed from scratching in both groups at the baseline, 4 th and (Fig. 4) . There was no significant difference between two groups at the baseline (P = 0.443), and there were no significant intra groups differences in both groups in 4 th week (p = 1, p = 0.1196) and 8 th week
(p = 0.1581, p = 0.007).
Discussion
The aim of this Randomized, placebo-controlled study was to compare the effect of S. ebulus fruits extract topical gel 2% with placebo on uremic pruritus. Less than half of patients were previously treated unsuccessfully with antihistamines and topical steroids, but previously antihistamine"s non effectiveness has been investigated and they make a good feeling in patinets with mild sedative effect (3). Topical gel was chosen as selected dosage form. This topical preparation is not greasy and spread readily on the skin. The low oily effect of this dosage form make it more compliant rather than other topical preparations.In this study a significant reduction in pruritus severity was observed after 4 and 8 weeks but the difference between both groups was not statistically significant. Rayner et al. was investigated the effect of gabapentin and pregabalin on uremic pruritus in 71 patients in 2013.
Starting dose of gabapentin was 100 mg after dialysis or daily. Patients who experienced side effects with gabapentin were treated with pregabalin, starting dose 25 mg after dialysis or daily. Gabapentin or pregabalin relieved itching in 60 patients (85%), median follow -up 2 months. Unless renal elimination and side effects of these medicine must be considered (22) . Nalfurafine, a selective agonist of kappa receptor has been approved for resistant pruritus. This open-label prospective study examined the effects of 52week oral administration of 5 µg/day nalfurafine hydrochloride in 211 hemodialysis patients and produced a long-term without significant safety problems (23) . As microinflammatory processes may be involved in the pathogenes is of uremic pruritus, in another study 22 Patients applied Tacrolimus 0.01%-ointment twice a day for 4 weeks, a strong reduction of pruritus severity was obtained but the differences between case and control groups wasn"t statistically significant (24) . In previous studies were investigated wound healing and anti-inflammatory effects of different part of S. ebulus extract. (25) . A large number of patients suffered from xerosis related to CKD (Chronic Kidney Disease), it is likely that xerosis has the synergistic effect with other pathogens on pruritus severity. In this study there were no significant differences in xerosis between two groups and no significant improvements were obtained in both groups in this parameter at the end of the study. A study was performed on 100 patients with moderate to severe uremic xerosis. Case group applied an emulsion combining glycerol and paraffin twice a day for 7 days on one allocated lower leg, and the emulsion preparation (comparator) on the other lower leg. A significant improvement of the uremic pruritus and quality of life of the patients at end of the study (P < 0.001, intragroup analysis) were investigated (26) . Due to this synergistic effect it would be better if we used oil-based production.
In number of patients who making themselves bleed from scratching in both group at the baseline there was no significant difference. No change was obtained in case group between 4 th and 8 th week, and a minor change was obtained in control group between 4 th and 8 th week but it is not statistically significant. This study showed statistically similar results in two groups. It seems that some antipruritic effects of placebo were related to its hydrating, anesthetics and cooling effects.
Conclusion
The present study showed that S. ebulus gel reduced the pruritus severity and improved symptoms but no significant difference was observed between S. ebulus and placebo gel, although furtherstudies are needed to confirm the results.
